Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

GLP-1-Based Therapies Across the Menopausal Transition: Dermatologic Considerations and Practical Management.

Created on 10 Nov 2026

Authors

Stephanie Sanchez-Melendez, Rita Linkner

Published in

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. Nov 10, 2026. Epub Nov 10, 2026.

Abstract

Glucagon-like peptide-1-based therapies have transformed obesity management. Their growing use among perimenopausal and menopausal women introduces new dermatologic considerations, particularly when weight loss occurs alongside menopause-associated changes in skin, adipose tissue, muscle, bone, and hair.
To provide a practical framework for dermatologic management of perimenopausal and menopausal women receiving glucagon-like peptide-1-based therapies.
PubMed was searched from inception through September 2026 for literature on Glucagon-like peptide-1-based therapies, menopause, skin aging, lean mass, alopecia, and aesthetic procedures. Reference lists of relevant reviews and consensus statements were also hand-searched. The senior author, a dermatologist and obesity medicine specialist, provides a practice-based perspective.
Key considerations include weight-loss trajectory, lean mass and bone preservation, nutrition, hair changes, procedural timing, and multidisciplinary comanagement. A staged aesthetic approach prioritizes skin quality during active weight loss, with structural correction as weight stabilizes.
Dermatologic care should anticipate the overlapping effects of menopause and substantial weight loss. A longitudinal, tissue-preservation approach may shift care from reactive correction toward proactive management.

PMID:
43002621
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement